TY - JOUR
T1 - Continuous manufacturing of tablets with PROMIS-line - Introduction and case studies from continuous feeding, blending and tableting
AU - Simonaho, Simo Pekka
AU - Ketolainen, Jarkko
AU - Ervasti, Tuomas
AU - Toiviainen, Maunu
AU - Korhonen, Ossi
PY - 2016/7/30
Y1 - 2016/7/30
N2 - Drug manufacturing technology is in the midst of modernization and continuous manufacturing of drug products is especially the focus of great interest. The adoption of new manufacturing approaches requires extensive cooperation between industry, regulatory bodies, academics and equipment manufacturers. In this paper we introduce PROMIS-line which is a continuous tableting line built at the University of Eastern Finland, School of Pharmacy, PROMIS-centre. PROMIS-line is modular and tablets can be produced via dry granulation or direct compression. In three case studies, continuous feeding, blending and tablet performance is studied to illustrate some basic features of PROMIS-line. In conclusion, the PROMIS-line is an excellent tool for studying the fundamentals of continuous manufacturing of tablets.
AB - Drug manufacturing technology is in the midst of modernization and continuous manufacturing of drug products is especially the focus of great interest. The adoption of new manufacturing approaches requires extensive cooperation between industry, regulatory bodies, academics and equipment manufacturers. In this paper we introduce PROMIS-line which is a continuous tableting line built at the University of Eastern Finland, School of Pharmacy, PROMIS-centre. PROMIS-line is modular and tablets can be produced via dry granulation or direct compression. In three case studies, continuous feeding, blending and tablet performance is studied to illustrate some basic features of PROMIS-line. In conclusion, the PROMIS-line is an excellent tool for studying the fundamentals of continuous manufacturing of tablets.
KW - Blending
KW - Continuous manufacturing
KW - Feeding
KW - Tableting
UR - http://www.scopus.com/inward/record.url?scp=85012256244&partnerID=8YFLogxK
U2 - 10.1016/j.ejps.2016.02.006
DO - 10.1016/j.ejps.2016.02.006
M3 - Article
C2 - 26879237
AN - SCOPUS:85012256244
SN - 0928-0987
VL - 90
SP - 38
EP - 46
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
ER -